Answers are grounded in this paper and cite their sources.
Wild-type Arabidopsis shows reduced biomass from growth-promoting rhizobacteria, indicating salicylic acid limits efficacy.
Wild-type levels of SA limited Ps WCS417r-mediated plant growth, as the SA-deficient Arabidopsis mutant sid2-2 accumulated more biomass in response to Ps WCS417r treatment than did the wild-type plants in response to Ps WCS417r treatment, and the SA-overaccumulator cpr5 yielded less biomass than did the wild-type plants. Analysis of previously generated and publicly available plant gene expression datasets revealed modest downregulation of EPS1, a key gene that contributes to SA accumulation, in the roots of Arabidopsis wild-type plants treated with Ps WCS417r. These results suggest that SA accumulation strongly limits the potential of some plant growth-promoting rhizobacteria, potentially minimizing their effectiveness in ensuring sustainable agriculture that is less reliant on chemical fertilizers.
No takes yet. Share an insight, caveat, or question.
Israel D. K. Agorsor (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: